Adverse Event Information. Within six months after the commencement of the Development Phase, MMD will establish a protocol for the timely handling and transmission of adverse event information. MMD and TKT shall promptly notify each other of any adverse event information relating to * in accordance with such protocol.
Appears in 2 contracts
Samples: License Agreement (Transkaryotic Therapies Inc), License Agreement (Transkaryotic Therapies Inc)
Adverse Event Information. Within six months after the commencement of the Development Phase, MMD will establish a protocol for the timely handling and transmission of adverse event information. MMD and TKT shall promptly notify each other of any adverse event information relating to * GA-EPO in accordance with such protocol.
Appears in 2 contracts
Samples: License Agreement (Transkaryotic Therapies Inc), License Agreement (Transkaryotic Therapies Inc)